SkinBioTherapeutics will be attending and presenting at the Shares and AJ Bell evening event in Manchester on October 10 2018 at the Macdonald Manchester Hotel (nr Piccadilly Station). Shareholders and potential investors can register now for free at: https://www.sharesmagazine.co.uk/events...
SkinBiotix® technology successful in stability testing
Manchester, UK - 03 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide an update to its announcement of 16 August 2018. The stability criteria required for its human study has been met and the Company e...
Manchester, UK - 16 August 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide the following update:...
SkinBioTherapeutics to present on 12 September 2018 at the Shares and AJ Bell Spotlight Evening in Edinburgh. Shareholders and potential investors can register now for free at: https://www.sharesmagazine.co.uk/events...
SkinBioTherapeutics receives provisional ethics approval for human study
Manchester, UK - 18 July 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life sciences company focused on skin health, announces that it has received provisional ethics approval for its human study scheduled to start later this year....